nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cardinal sin when researching neuropsin/KLK8: Thou shalt validate antibodies
|
Lahiri, Debomoy K. |
|
2017 |
|
9 |
p. 1068-1069 |
artikel |
2 |
Alzheimer's Association Update
|
|
|
2015 |
|
9 |
p. 1127-1129 3 p. |
artikel |
3 |
Amyloid-beta oligomerization is associated with the generation of a typical peptide fragment fingerprint
|
Rudinskiy, Nikita |
|
2016 |
|
9 |
p. 996-1013 18 p. |
artikel |
4 |
Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort
|
Tosun, Duygu |
|
2016 |
|
9 |
p. 977-986 10 p. |
artikel |
5 |
APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies
|
Saeed, Usman |
|
2018 |
|
9 |
p. 1137-1147 |
artikel |
6 |
Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation
|
Haas, Magali |
|
2016 |
|
9 |
p. 1022-1030 9 p. |
artikel |
7 |
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge
|
Geerts, Hugo |
|
2016 |
|
9 |
p. 1014-1021 8 p. |
artikel |
8 |
Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform
|
Vaudano, Elisabetta |
|
2015 |
|
9 |
p. 1121-1122 2 p. |
artikel |
9 |
Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications
|
Karageorgiou, Elissaios |
|
2017 |
|
9 |
p. 1054-1067 |
artikel |
10 |
Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?
|
Lehmann, Sylvain |
|
2015 |
|
9 |
p. 1125-1126 2 p. |
artikel |
11 |
Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration
|
Alosco, Michael L. |
|
2018 |
|
9 |
p. 1159-1170 |
artikel |
12 |
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome
|
Sakae, Nobutaka |
|
|
|
9 |
p. 1218-1228 |
artikel |
13 |
Cognitive decline associated with pathological burden in primary age-related tauopathy
|
Jefferson-George, Kyra S. |
|
2017 |
|
9 |
p. 1048-1053 |
artikel |
14 |
Combination therapy for Alzheimer's disease: Are we ready?
|
Salloway, Stephen |
|
2018 |
|
9 |
p. 1232-1233 |
artikel |
15 |
Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer’s disease
|
Lanctôt, Krista L. |
|
2016 |
|
9 |
p. 1031-1032 2 p. |
artikel |
16 |
Contents
|
|
|
2017 |
|
9 |
p. A1-A2 |
artikel |
17 |
Contents
|
|
|
2018 |
|
9 |
p. A1-A2 |
artikel |
18 |
Contents
|
|
|
2016 |
|
9 |
p. A1-A2 nvt p. |
artikel |
19 |
Contents
|
|
|
2015 |
|
9 |
p. A1-A2 nvt p. |
artikel |
20 |
Contents
|
|
|
|
|
9 |
p. A1-A2 |
artikel |
21 |
Dementia registries around the globe and their applications: A systematic review
|
Krysinska, Karolina |
|
2017 |
|
9 |
p. 1031-1047 |
artikel |
22 |
Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
|
Dubois, Bruno |
|
2015 |
|
9 |
p. 1041-1049 9 p. |
artikel |
23 |
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
|
Mormino, Elizabeth C. |
|
2017 |
|
9 |
p. 1004-1012 |
artikel |
24 |
Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition
|
Shah, Disha |
|
2016 |
|
9 |
p. 964-976 13 p. |
artikel |
25 |
Editorial Board
|
|
|
2016 |
|
9 |
p. A3- 1 p. |
artikel |
26 |
Editorial Board
|
|
|
2017 |
|
9 |
p. A3 |
artikel |
27 |
Editorial Board
|
|
|
2018 |
|
9 |
p. A3-A4 |
artikel |
28 |
Editorial Board
|
|
|
2015 |
|
9 |
p. A3- 1 p. |
artikel |
29 |
Editorial Board
|
|
|
|
|
9 |
p. A3-A4 |
artikel |
30 |
Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study
|
Teipel, Stefan J. |
|
2018 |
|
9 |
p. 1126-1136 |
artikel |
31 |
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model
|
Mandler, Markus |
|
|
|
9 |
p. 1133-1148 |
artikel |
32 |
Epilepsy and Alzheimer's disease: Overlapping mechanisms and therapeutic opportunities
|
Alzheimer's, |
|
|
|
9 |
p. 1240-1241 |
artikel |
33 |
Ethical adoption: A new imperative in the development of technology for dementia
|
Robillard, Julie M. |
|
2018 |
|
9 |
p. 1104-1113 |
artikel |
34 |
18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET
|
Ottoy, Julie |
|
|
|
9 |
p. 1172-1182 |
artikel |
35 |
Fractal regulation and incident Alzheimer's disease in elderly individuals
|
Li, Peng |
|
2018 |
|
9 |
p. 1114-1125 |
artikel |
36 |
Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
|
Yu, Jin-Tai |
|
|
|
9 |
p. 1208-1217 |
artikel |
37 |
Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study
|
Kunutsor, Setor K. |
|
2016 |
|
9 |
p. 931-941 11 p. |
artikel |
38 |
Guidelines for reporting methodological challenges and evaluating potential bias in dementia research
|
Weuve, Jennifer |
|
2015 |
|
9 |
p. 1098-1109 12 p. |
artikel |
39 |
Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys
|
Beydoun, May A. |
|
2018 |
|
9 |
p. 1148-1158 |
artikel |
40 |
Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on “CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease” by Lista et al.
|
Diomedi, Marina |
|
2015 |
|
9 |
p. 1123-1124 2 p. |
artikel |
41 |
Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology
|
Meyer, Pierre-François |
|
|
|
9 |
p. 1160-1171 |
artikel |
42 |
Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
|
Varley, James |
|
2015 |
|
9 |
p. 1110-1120 11 p. |
artikel |
43 |
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials
|
Donohue, Michael C. |
|
2015 |
|
9 |
p. 1069-1079 11 p. |
artikel |
44 |
Medical and Scientific Advisory Council
|
|
|
2017 |
|
9 |
p. A4 |
artikel |
45 |
Medical and Scientific Advisory Council
|
|
|
2018 |
|
9 |
p. A5 |
artikel |
46 |
Medical and Scientific Advisory Council
|
|
|
2016 |
|
9 |
p. A4- 1 p. |
artikel |
47 |
Medical and Scientific Advisory Council
|
|
|
2015 |
|
9 |
p. A4- 1 p. |
artikel |
48 |
Medical and Scientific Advisory Council
|
|
|
|
|
9 |
p. A5 |
artikel |
49 |
Mediterranean diet and preserved brain structural connectivity in older subjects
|
Pelletier, Amandine |
|
2015 |
|
9 |
p. 1023-1031 9 p. |
artikel |
50 |
Metabolic network failures in Alzheimer's disease: A biochemical road map
|
Toledo, Jon B. |
|
2017 |
|
9 |
p. 965-984 |
artikel |
51 |
Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology
|
Yu, Lei |
|
2016 |
|
9 |
p. 942-951 10 p. |
artikel |
52 |
MIND diet associated with reduced incidence of Alzheimer's disease
|
Morris, Martha Clare |
|
2015 |
|
9 |
p. 1007-1014 8 p. |
artikel |
53 |
MIND diet slows cognitive decline with aging
|
Morris, Martha Clare |
|
2015 |
|
9 |
p. 1015-1022 8 p. |
artikel |
54 |
Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life
|
Liu, Lei |
|
|
|
9 |
p. 1183-1194 |
artikel |
55 |
Neuropsychological latent classes at enrollment and postmortem neuropathology
|
Zammit, Andrea R. |
|
|
|
9 |
p. 1195-1207 |
artikel |
56 |
Paul Greengard, Ph.D. (1925-2019)
|
Gandy, Sam |
|
|
|
9 |
p. 1229-1235 |
artikel |
57 |
Potential roles of digital technologies in clinical trials
|
Czaja, Sara |
|
2017 |
|
9 |
p. 1075-1076 |
artikel |
58 |
Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”
|
Startin, Carla M. |
|
|
|
9 |
p. 1238-1239 |
artikel |
59 |
Response letter
|
Keyvani, Kathy |
|
2017 |
|
9 |
p. 1070-1071 |
artikel |
60 |
Safety of disclosing amyloid status in cognitively normal older adults
|
Burns, Jeffrey M. |
|
2017 |
|
9 |
p. 1024-1030 |
artikel |
61 |
Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease
|
Rueda, Alicia D. |
|
2015 |
|
9 |
p. 1080-1089 10 p. |
artikel |
62 |
Self-reported sleep disturbance is associated with Alzheimer's disease risk in men
|
Benedict, Christian |
|
2015 |
|
9 |
p. 1090-1097 8 p. |
artikel |
63 |
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
|
Buckley, Rachel F. |
|
2018 |
|
9 |
p. 1193-1203 |
artikel |
64 |
Sex and gender in Alzheimer's disease – Does it matter?
|
Mielke, Michelle M. |
|
2018 |
|
9 |
p. 1101-1103 |
artikel |
65 |
Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints
|
Cavedo, Enrica |
|
2018 |
|
9 |
p. 1204-1215 |
artikel |
66 |
Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes
|
Espeland, Mark A. |
|
2018 |
|
9 |
p. 1184-1192 |
artikel |
67 |
SORLA regulates calpain-dependent degradation of synapsin
|
Hartl, Daniela |
|
2016 |
|
9 |
p. 952-963 12 p. |
artikel |
68 |
Spatial navigation and risk of cognitive impairment: A prospective cohort study
|
Verghese, Joe |
|
2017 |
|
9 |
p. 985-992 |
artikel |
69 |
Subscriber Information
|
|
|
2017 |
|
9 |
p. A5 |
artikel |
70 |
Subscriber Information
|
|
|
2018 |
|
9 |
p. A6 |
artikel |
71 |
Subscriber Information
|
|
|
2016 |
|
9 |
p. A5- 1 p. |
artikel |
72 |
Subscriber Information
|
|
|
2015 |
|
9 |
p. A5- 1 p. |
artikel |
73 |
Subscriber Information
|
|
|
|
|
9 |
p. A6 |
artikel |
74 |
Sugary beverage intake and preclinical Alzheimer's disease in the community
|
Pase, Matthew P. |
|
2017 |
|
9 |
p. 955-964 |
artikel |
75 |
The Alzheimer's Disease Exposome
|
Finch, Caleb E. |
|
|
|
9 |
p. 1123-1132 |
artikel |
76 |
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
|
Bosco, Paolo |
|
2017 |
|
9 |
p. 1013-1023 |
artikel |
77 |
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
|
Schmidt, Mark E. |
|
2015 |
|
9 |
p. 1050-1068 19 p. |
artikel |
78 |
The pitfalls of biomarker-based classification schemes
|
Illán-Gala, Ignacio |
|
2017 |
|
9 |
p. 1072-1074 |
artikel |
79 |
The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment
|
Ozer, Seline |
|
2016 |
|
9 |
p. 987-995 9 p. |
artikel |
80 |
Transcranial direct current stimulation in mild cognitive impairment: Behavioral effects and neural mechanisms
|
Meinzer, Marcus |
|
2015 |
|
9 |
p. 1032-1040 9 p. |
artikel |
81 |
Traumatic brain injury and Alzheimer's disease neuropathology
|
Jellinger, Kurt A. |
|
|
|
9 |
p. 1236-1237 |
artikel |
82 |
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
|
Baldacci, Filippo |
|
2017 |
|
9 |
p. 993-1003 |
artikel |
83 |
Understanding the impact of sex and gender in Alzheimer's disease: A call to action
|
Nebel, Rebecca A. |
|
2018 |
|
9 |
p. 1171-1183 |
artikel |
84 |
Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia
|
Teipel, Stefan |
|
2018 |
|
9 |
p. 1216-1231 |
artikel |
85 |
Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
|
Bos, Isabelle |
|
|
|
9 |
p. 1149-1159 |
artikel |